Related Party Transactions

12 Months Ended

Jun. 30, 2019

Related Party Transactions

Related Party Transactions

Note 19.  Related Party Transactions

The Company had sales of $3.8 million, $3.9 million and $3.7 million during the fiscal years ended June 30, 2019, 2018 and 2017, respectively, to a generic distributor, Auburn Pharmaceutical Company (“Auburn ”), which is a member of the Premier Buying Group.  Jeffrey Farber, a current board member, is the owner of Auburn.  Accounts receivable includes amounts due from Auburn of $1.2 million and $0.6 million at June 30, 2019 and 2018, respectively.

The Company also had net sales of $2.4 million and $1.9 million during the fiscal years ended June 30, 2019 and 2018 to a generic distributor, KeySource Medical (“KeySource ”), which is a member of the OptiSource Buying Group.  Albert Paonessa, a current board member, was appointed the CEO of KeySource in May 2017.  Accounts receivable includes amounts due from KeySource of $0.7 million and $0.5 million as of June 30, 2019 and 2018.

The Company incurred expenses totaling $0.4 million and $0.3 million during the fiscal years ended June 30, 2019 and June 30, 2018 , respectively, for online medical benefit services provided by a subsidiary of a variable interest entity.  See Note 12. “Commitments” for more information.  There were no  amounts due to the variable interest entity as of June 30, 2019 . The liability was not material to the financial position of the Company as of June 30,2018.